Webb7 okt. 2024 · Rich Pharmaceuticals, Inc. undertakes no obligation to revise these statements following the date of this news release. Tags Geopulse Exploration Inc. Rich … WebbRich Pharmaceuticals Inc is a biopharmaceutical company. The Company develops RP-323 (12-O-tetradecanoylphorbol-13-acetate), for the treatment of acute myelogenous …
Rich Pharmaceuticals, Inc. (RCHA) 10K Annual Reports & 10Q SEC …
Webb14 mars 2024 · BEVERLY HILLS, CA , March 14, 2024 (GLOBE NEWSWIRE) -- Rich Pharmaceuticals, Inc. (OTC: RCHA ), a Biopharmaceutical Company focused on … Webb28 okt. 2024 · RICH PHARMACEUTICALS, INC. (RCHA) Add to my list. End-of-day quote OTC Markets - 2024-10-28 0.000500: USD -.--% 2024: Rich Pharmaceuticals, Inc. : Change in Directors or Principal Officers (form 8-K) AQ. 2024: Rich Pharmaceuticals, Inc ... golfbuddy platinum user manual
Rich Pharmaceuticals Inc (RCHA) - se.investing.com
WebbInformation om Rich Pharma aktie (RCHA aktie idag) inklusive diagram, historisk data, analyser, Rich Pharma aktiekurs och mer. Investing.com - Den ledande finansiella webbportalen Öppna appen WebbRich Pharmaceuticals Inc (RCHA) OTC Markets Create Alert Add to Watchlist Rich Pharma historical data, for real-time data please try another search 0.00050 0.00000 0.00% … WebbRich Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing therapies in oncology. It is developing RP-323 for the treatment of Hodgkin’s lymphoma, acute ... headwaters center for lifelong learning